Search results
Results from the WOW.Com Content Network
Bystolic is associated with a number of serious risks. Bystolic is contraindicated in patients with severe bradycardia, heart block greater than first degree, cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (unless a permanent pacemaker is in place), severe hepatic impairment (Child-Pugh > B) and in patients who are ...
Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP) (transl. Prime Minister’s Indian Public Medicine Scheme) is a campaign and public welfare scheme of the Government of India, launched in 2008 as the Jan Aushadhi Scheme by the Ministry of Chemicals and Fertilizers.
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology. . The company's drugs reach 70 countries [22] with a footprint that covers advanced markets such as USA, Europe, Japan, [23] Australia as well as emerging markets including India, the Philippines and South Africa to name a
According to Dr. Niteesh K. Choudhry, professor of medicine at Harvard Medical School and executive director of the Center for Healthcare Delivery Sciences at Brigham and Women’s Hospital, if ...
For premium support please call: 800-290-4726 more ways to reach us
In 1999, Cipla joined the Indian Pharmaceutical Alliance as a founding member in an effort to promote the development of generic drugs in India. [ 8 ] [ 9 ] During the AIDS epidemic in the early 2000s, Hamied reverse-engineered a three-drug antiretroviral medication that was sold for about $12,000 per year to create a cheaper version that sold ...
Forest Laboratories announced today it has agreed to settle the patent infringement lawsuit it had brought against Glenmark Generics. That litigation was in response to Glenmark's seeking approval ...
Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. [6] Aurobindo exports to over 125 countries with more than 70% of its revenues derived out of international operations. In 2014, Aurobindo purchased the generic operations of Actavis in 7 Western European countries for $41 million. [10] [11]